Assistant Professor
My laboratory develops novel immunotherapies for rare solid tumors and inflammatory conditions. We engineer therapeutic antibodies with two key goals: harnessing immune cells’ natural ability to destroy cancer and blocking specific receptors to control inflammation. Our mission is to advance these novel treatments to the clinic, particularly focusing on rare disease patients who have limited therapeutic options.